This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Solazyme Reports Third Quarter 2012 Results

Stocks in this article: SZYM

In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.

SOLAZYME, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three and nine months ended September 30, 2012 and 2011

In thousands, except per share amounts

 
  Three Months Ended September 30, Nine Months Ended September 30,
  2012       2011     2012       2011  

Revenues

(Unaudited) (Unaudited)
Research and development programs $ 4,810   $ 7,051 $ 23,838   $ 18,542
Product revenues 3,773 1,886 11,846 5,535
           
Total revenues 8,583 8,937 35,684 24,077
 

Costs and operating expenses (1)

Cost of product revenue 1,331 554 3,907 1,592
Research and development 16,534 10,866 50,276 28,692
Sales, general and administrative   13,849       11,527     41,628       28,591  
Total costs and operating expenses 31,714 22,947 95,811 58,875
           
Loss from operations (23,131 ) (14,010 ) (60,127 ) (34,798 )
 

Other income (expense)

Interest and other income (expense), net 626 (76 ) 1,262 115
Loss on equity method investment (683 ) - (1,193 ) -
Gain (Loss) from change in fair value of warrant liability   685       -     1,536       (3,637 )
Total other income (expense) 628 (76 ) 1,605 (3,522 )
           
Net Loss (22,503 ) (14,086 ) (58,522 ) (38,320 )
 
Accretion of redeemable convertible preferred stock   -       -     -       (60 )
 
Net loss attributable to Solazyme, Inc. common stockholders $ (22,503 )   $ (14,086 ) $ (58,522 )   $ (38,380 )
 
Net loss per share attributable to Solazyme, Inc. common stockholders, basic and diluted $ (0.37 )   $ (0.24 ) $ (0.97 )   $ (1.15 )
 
Weighted average number of common shares used in loss per share computation, basic and diluted 60,678 59,508 60,387 33,272
 
 
 
 
 
 
 
Reconciliation of GAAP to non-GAAP basic net loss per share: Three Months Ended September 30, Nine Months Ended September 30,
In thousands, except per share amounts   2012       2011     2012       2011  
(Unaudited) (Unaudited)
Net loss attributable to Solazyme, Inc. common stockholders $ (22,503 ) $ (14,086 ) $ (58,522 ) $ (38,380 )
 
Gain (Loss) from change in fair value of warrant liability (685 ) - (1,536 ) 3,637
(1) Operating expenses include stock-based compensation expense as follows:
Research and development 1,001 534 2,939 1,567
Sales, general and administrative   2,742       2,018     8,619       6,008  
Total stock-based compensation expense 3,743 2,552 11,558 7,575
           
Net loss attributable to Solazyme, Inc. common stockholders (non-GAAP) $ (19,445 )   $ (11,534 ) $ (48,500 )   $ (27,168 )
 
Basic and diluted loss per share attributable to Solazyme, Inc. common stockholders (GAAP) $ (0.37 ) $ (0.24 ) $ (0.97 ) $ (1.15 )
 
Gain (Loss) from change in fair value of warrant liability (0.01 ) - (0.02 ) 0.11
Stock-based compensation expense 0.06 0.05 0.19 0.22
           
Net loss per share attributable to Solazyme,Inc. common stockholders (non-GAAP) $ (0.32 )   $ (0.19 ) $ (0.80 )   $ (0.82 )
 
 
SOLAZYME, INC.
Condensed Consolidated Balance Sheets September 30, December 31,
In thousands   2012       2011  
(Unaudited) (Unaudited)

Assets

 

Current assets

Cash, cash equivalents and marketable securities $ 167,101 $ 243,724
Other current assets 18,353 15,169
     
Total current assets 185,454 258,893
 
Property, plant and equipment - net 32,269 25,985
Other assets 20,010 346
     
Total assets $ 237,733     $ 285,224  
 

Liabilities and stockholders' equity

 

Current liabilities

Current portion of long-term debt $ 7,255 $ 5,289
Other current liabilities 15,894 23,923
     
Total current liabilities 23,149 29,212
 
Other liabilities 1,936 491
Long-term debt   8,587       14,963  
Total liabilities   33,672       44,666  
Total stockholders' equity 204,061 240,558
     
Total liabilities and stockholders' equity $ 237,733     $ 285,224  




4 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,195.42 +221.11 1.30%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,566.1380 +16.9120 0.37%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs